FDA product code GXP: Methyl Methacrylate For Cranioplasty
GXP is the FDA product code for methyl methacrylate for cranioplasty. It is a Class II device, regulated under 21 CFR 882.5300 and reviewed by the Neurology panel. FDA has cleared 45 510(k) submissions under GXP, 8 in the last five years, from 26 different applicants. The average 510(k) review took 153 days (median 109); 156 days on average over the last three years. FDA has posted 30 recalls for GXP devices.
Classification
| Field | Value |
|---|---|
| Device name | Methyl Methacrylate For Cranioplasty |
| Device class | Class II |
| Regulation | 21 CFR 882.5300 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
| Implant | Yes |
510(k) clearances per year for GXP
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 1 | 92 |
| 2019 | 1 | 265 |
| 2023 | 2 | 170 |
| 2024 | 2 | 161 |
| 2026 | 4 | 150 |
Compare with all 510(k) review times · Search every GXP clearance
Top GXP applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Orthocon, Inc. | 7 | 2026-06-15 |
| Synthes (Usa) | 4 | 2006-04-13 |
| Biomet, Inc. | 4 | 2004-12-21 |
| Skeletal Kinetics, LLC | 3 | 2017-01-13 |
| Stryker Instruments | 3 | 2005-02-09 |
21 more applicants have GXP clearances. See the full list in Caduvo.
Most recent GXP clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K251959 | T&R BIOFAB CO., Ltd. | TnR Cranial Implant | 2026-07-30 | 399 |
| K261265 | Orthocon, Inc. | Permatage XT Settable Bone Putty | 2026-06-15 | 60 |
| K253732 | Orthocon, Inc. | Permatage Flowable, Settable Bone Paste | 2026-03-13 | 109 |
| K253854 | Orthocon, Inc. | MONTAGE XT Cranial Cement | 2026-01-02 | 30 |
| K241027 | Orthocon, Inc. | Permatage Settable Bone Putty | 2024-09-26 | 164 |
Recalls for GXP devices
30 product recalls in 8 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2021-04-01.
| Year | Recalls |
|---|---|
| 2019 | 2 |
| 2020 | 23 |
| 2021 | 1 |
Frequently asked questions
What is FDA product code GXP?
GXP is the FDA product code for methyl methacrylate for cranioplasty. It is a Class II device, regulated under 21 CFR 882.5300 and reviewed by the Neurology panel.
What device class is GXP?
Class II, regulation 21 CFR 882.5300. Typical premarket route: 510(k).
How long does a 510(k) take for product code GXP?
Across 45 cleared submissions the average was 153 days from receipt to decision (median 109).
Which companies have the most GXP clearances?
Orthocon, Inc. (7); Synthes (Usa) (4); Biomet, Inc. (4); Skeletal Kinetics, LLC (3); Stryker Instruments (3).
Have GXP devices been recalled?
Yes: 30 product recalls across 8 recall events; the most recent began 2021-04-01.
Next steps
- Run an FDA pathway report with predicate devices for product code GXP
- Run a recall and safety report across every GXP manufacturer
- Watch product code GXP for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times